{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:07:24Z","timestamp":1792976844962,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1124\/jpet.121.000532","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T15:05:31Z","timestamp":1620918331000},"page":"51-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["MC-100093, a Novel \u03b2-Lactam Glutamate Transporter-1 Enhancer Devoid of Antimicrobial Properties, Attenuates Cocaine Relapse in Rats"],"prefix":"10.1016","volume":"378","author":[{"given":"Lori A","family":"Knackstedt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Rothstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Vidensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercy","family":"Ramanjulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Dunman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Blass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Childers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magid","family":"Abou-Gharbia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.121.000532_bib1","unstructured":"Abou-Gharbia M, Childers W, Martinez R, Ramanjulu M and Blass B (2018) inventors. Beta lactams as modulators of glutamate uptake and methods for use thereof. U.S. Patent 9,975,879 B"},{"key":"10.1124\/jpet.121.000532_bib2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Automat Contr"},{"key":"10.1124\/jpet.121.000532_bib3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00213-017-4802-7","article-title":"The effects of ceftriaxone on cue-primed reinstatement of cocaine-seeking in male and female rats: estrous cycle effects on behavior and protein expression in the nucleus accumbens","volume":"235","author":"Bechard","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.121.000532_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1037\/bne0000297","article-title":"The effects of clavulanic acid and amoxicillin on cue-primed reinstatement of cocaine seeking","volume":"133","author":"Bechard","year":"2019","journal-title":"Behav Neurosci"},{"key":"10.1124\/jpet.121.000532_bib5","doi-asserted-by":"crossref","first-page":"e12928","DOI":"10.1111\/adb.12928","article-title":"Role of prefrontal cortex projections to the nucleus accumbens core in mediating the effects of ceftriaxone on cue-induced cocaine seeking","volume":"26","author":"Bechard","year":"2021","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.121.000532_bib6","doi-asserted-by":"crossref","first-page":"e34139","DOI":"10.1371\/journal.pone.0034139","article-title":"Reduction of EEG theta power and changes in motor activity in rats treated with ceftriaxone","volume":"7","author":"Bellesi","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/jpet.121.000532_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature11691","article-title":"Automated design of ligands to polypharmacological profiles","volume":"492","author":"Besnard","year":"2012","journal-title":"Nature"},{"key":"10.1124\/jpet.121.000532_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2005.09.030","article-title":"Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications","volume":"526","author":"Bossert","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.121.000532_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/10408440802026307","article-title":"U-shaped dose response in behavioral pharmacology: historical foundations","volume":"38","author":"Calabrese","year":"2008","journal-title":"Crit Rev Toxicol"},{"key":"10.1124\/jpet.121.000532_bib10","unstructured":"Center for Behavioral Health Statistics and Quality (2015) Behavioral health trends in the united states: results from the 2014 national survey on drug use and health (HHS Publication No. SMA 15-4927, NSDUH Series H-50). Retrieved from http:\/\/www.samhsa.gov\/data\/"},{"key":"10.1124\/jpet.121.000532_bib11","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1128\/AAC.04352-14","article-title":"Small-molecule inhibitors of Staphylococcus aureus RnpA-mediated RNA turnover and tRNA processing","volume":"59","author":"Eidem","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.121.000532_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-006-0529-6","article-title":"Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure","volume":"189","author":"Epstein","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.121.000532_bib13","doi-asserted-by":"crossref","first-page":"9319","DOI":"10.1523\/JNEUROSCI.3278-12.2013","article-title":"Role of the major glutamate transporter GLT1 in nucleus accumbens core versus shell in cue-induced cocaine-seeking behavior","volume":"33","author":"Fischer","year":"2013","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.121.000532_bib14","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1128\/AAC.39.12.2728","article-title":"Analysis of ceftriaxone and ceftazidime distribution in cerebrospinal fluid of and cerebral extracellular space in awake rats by in vivo microdialysis","volume":"39","author":"Granero","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.121.000532_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1124\/dmd.108.023853","article-title":"Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes","volume":"37","author":"Kilford","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.121.000532_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2017.09.019","article-title":"Regulation of glutamate transporter 1 (GLT-1) gene expression by cocaine self-administration and withdrawal","volume":"128","author":"Kim","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.121.000532_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biopsych.2009.07.018","article-title":"Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking","volume":"67","author":"Knackstedt","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.121.000532_bib16a","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1021\/mp800004s","article-title":"Impact of pH on plasma protein binding in equilibrium dialysis","volume":"5","author":"Kochansky","year":"2008","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.121.000532_bib18","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1523\/JNEUROSCI.3717-16.2017","article-title":"Contrasting the role of xCT and GLT-1 upregulation in the ability of ceftriaxone to attenuate the cue-induced reinstatement of cocaine seeking and normalize AMPA receptor subunit expression","volume":"37","author":"LaCrosse","year":"2017","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.121.000532_bib19","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1021\/jm0700060","article-title":"Inhibition of recombinant cytochrome P450 isoforms 2D6 and 2C9 by diverse drug-like molecules","volume":"50","author":"McMasters","year":"2007","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.121.000532_bib20","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"s2","key":"10.1124\/jpet.121.000532_bib21","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1080\/10550490390210092","article-title":"Research advances in the understanding and treatment of addiction","volume":"12","author":"O\u2019Brien","year":"2003","journal-title":"Am J Addict"},{"key":"10.1124\/jpet.121.000532_bib22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"NeuroRx"},{"key":"10.1124\/jpet.121.000532_bib23","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1073\/pnas.85.12.4486","article-title":"A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells","volume":"85","author":"Pastan","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.121.000532_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/npp.2013.223","article-title":"Chronic administration of the methylxanthine propentofylline impairs reinstatement to cocaine by a GLT-1-dependent mechanism","volume":"39","author":"Reissner","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.121.000532_bib25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1021\/acs.jmedchem.5b00832","article-title":"Orexin receptor antagonists: new therapeutic agents for the treatment of insomnia","volume":"59","author":"Roecker","year":"2016","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.121.000532_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","article-title":"Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"key":"10.1124\/jpet.121.000532_bib27","doi-asserted-by":"crossref","first-page":"9239","DOI":"10.1523\/JNEUROSCI.1746-09.2009","article-title":"Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats","volume":"29","author":"Sari","year":"2009","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.121.000532_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41398-018-0265-9","article-title":"A novel rat model of comorbid PTSD and addiction reveals intersections between stress susceptibility and enhanced cocaine seeking with a role for mGlu5 receptors","volume":"8","author":"Schwendt","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1124\/jpet.121.000532_bib29","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/npp.2017.244","article-title":"Riluzole impairs cocaine reinstatement and restores adaptations in intrinsic excitability and GLT-1 expression","volume":"43","author":"Sepulveda-Orengo","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.121.000532_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neubiorev.2020.05.016","article-title":"Molecular changes evoked by the beta-lactam antibiotic ceftriaxone across rodent models of substance use disorder and neurological disease","volume":"115","author":"Smaga","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.121.000532_bib31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157488911795933893","article-title":"Promising medications for cocaine dependence treatment","volume":"6","author":"Somaini","year":"2011","journal-title":"Recent Patents CNS Drug Discov"},{"key":"10.1124\/jpet.121.000532_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbr.2011.07.041","article-title":"Ceftriaxone prevents the induction of cocaine sensitization and produces enduring attenuation of cue- and cocaine-primed reinstatement of cocaine-seeking","volume":"225","author":"Sondheimer","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.121.000532_bib33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pbb.2014.10.001","article-title":"GLT-1 transporter: an effective pharmacological target for various neurological disorders","volume":"127","author":"Soni","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.121.000532_bib34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbr.2019.02.020","article-title":"A new avenue for treating neuronal diseases: Ceftriaxone, an old antibiotic demonstrating behavioral neuronal effects","volume":"364","author":"Tai","year":"2019","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.121.000532_bib35","doi-asserted-by":"crossref","first-page":"12406","DOI":"10.1523\/JNEUROSCI.1976-12.2012","article-title":"Ceftriaxone normalizes nucleus accumbens synaptic transmission, glutamate transport, and export following cocaine self-administration and extinction training","volume":"32","author":"Trantham-Davidson","year":"2012","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.121.000532_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijpharm.2004.10.007","article-title":"Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier","volume":"288","author":"Wang","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1124\/jpet.121.000532_bib37","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/FBP.0b013e3283473c10","article-title":"Beta-lactam antibiotic decreases acquisition of and motivation to respond for cocaine, but not sweet food, in C57Bl\/6 mice","volume":"22","author":"Ward","year":"2011","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.121.000532_bib38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fphar.2015.00044","article-title":"Ceftriaxone and cefazolin attenuate the cue-primed reinstatement of alcohol-seeking","volume":"6","author":"Weiland","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.121.000532_bib38a","unstructured":"Wikler MA, Lewis II JS, Moeck G, Nicolau DR and Satlin M (2018) CLSI M23-ED5: 2018 Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters, 5th Edition, Clinical and Laboratory Standards Institute, CLSI Guidelines. 2018. Available online at: http:\/\/em100.edaptivedocs.net\/GetDoc.aspx?doc=CLSI%20M23%20ED5:2018&scope=user"},{"key":"10.1124\/jpet.121.000532_bib39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1124\/dmd.106.013359","article-title":"Misuse of the well-stirred model of hepatic drug clearance","volume":"35","author":"Yang","year":"2007","journal-title":"Drug Metab Dispos"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524256901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524256901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.121.000532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:52:42Z","timestamp":1739973162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524256901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0022356524256901"],"URL":"https:\/\/doi.org\/10.1124\/jpet.121.000532","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MC-100093, a Novel \u03b2-Lactam Glutamate Transporter-1 Enhancer Devoid of Antimicrobial Properties, Attenuates Cocaine Relapse in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.121.000532","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}